Jason Alexander to Risk Assessment
This is a "connection" page, showing publications Jason Alexander has written about Risk Assessment.
Connection Strength
0.149
-
Longer-term Benefits and Risks of Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes: a Systematic Review and Meta-analysis. J Gen Intern Med. 2022 02; 37(2):439-448.
Score: 0.115
-
Lower Gastrointestinal Hemorrhage. JAMA. 2024 05 21; 331(19):1666-1667.
Score: 0.034